editorial | Q871232 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.NRL.2010.11.001 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0213485310003269?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0213485310003269?httpAccept=text/xml | ||
P698 | PubMed publication ID | 21216501 |
P50 | author | Jorge Matias-Guiu | Q88156479 |
P2093 | author name string | R. García-Ramos | |
P2860 | cites work | Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 |
Pharmaceutical industry sponsorship and research outcome and quality: systematic review | Q24673248 | ||
Composition of the editorial boards of leading medical education journals | Q24794261 | ||
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
The politics of publication | Q28185087 | ||
Publication bias in editorial decision making | Q28201785 | ||
Dissemination and publication of research findings: an updated review of related biases | Q28274123 | ||
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation | Q28276588 | ||
Publication bias in clinical research | Q29541186 | ||
Scope and impact of financial conflicts of interest in biomedical research: a systematic review | Q29616086 | ||
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
Country development and manuscript selection bias: a review of published studies. | Q33252381 | ||
Characteristics associated with citation rate of the medical literature | Q33283512 | ||
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? | Q33364538 | ||
Publication bias in meta-analysis: its causes and consequences | Q33870662 | ||
Uneasy alliance--clinical investigators and the pharmaceutical industry | Q33902207 | ||
North and South: bridging the information gap. | Q33958970 | ||
Publication bias and clinical trials | Q34179248 | ||
Representation of authors and editors from countries with different human development indexes in the leading literature on tropical medicine: survey of current evidence | Q34196625 | ||
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | Q34389549 | ||
The corporate coauthor | Q34723235 | ||
Ethical behaviour of authors in biomedical journalism | Q35130377 | ||
Publication bias: evidence of delayed publication in a cohort study of clinical research projects | Q36246225 | ||
Effect of blinded peer review on abstract acceptance | Q36445985 | ||
Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. | Q36520657 | ||
Publication bias in the medical literature: a review by a Canadian Research Ethics Board | Q36807233 | ||
Nonscientific factors associated with acceptance for publication in The Journal of Bone and Joint Surgery (American Volume). | Q37145442 | ||
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials | Q37751910 | ||
Scientific collaboration results in higher citation rates of published articles | Q40323359 | ||
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis | Q40590970 | ||
Effect of institutional prestige on reviewers' recommendations and editorial decisions | Q40663286 | ||
The effects of blinding on acceptance of research papers by peer review | Q40663298 | ||
Bias in location and selection of studies | Q41694445 | ||
Conforming to ICMJE principles | Q42673321 | ||
Literature is subject to publication bias | Q43119532 | ||
Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee | Q46059332 | ||
Assessment of epidemiological and HIV/AIDS publications in Africa | Q46758472 | ||
Impact-factor rewards affect Spanish research | Q48630079 | ||
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors | Q50106441 | ||
Publication languages of Impact Factor journals and of medical bibliographic databanks | Q50690316 | ||
Publication languages of Impact Factor journals and of medical bibliographic databanks (reprint) | Q50693853 | ||
Composition of the editorial/advisory boards of major English-language anesthesia/critical care journals | Q51415561 | ||
International representation in psychiatric literature: survey of six leading journals | Q51967204 | ||
How blind is blind review? | Q52864571 | ||
Publication bias and dissemination of clinical research | Q52867734 | ||
Overcoming the limitations of current meta-analysis of randomised controlled trials | Q52900034 | ||
US and non-US submissions: an analysis of reviewer bias | Q52904011 | ||
Bias against European journals in medical publication Databases | Q52912449 | ||
Fair conduct and fair reporting of clinical trials | Q52916957 | ||
Direction and impact of language bias in meta-analyses of controlled trials: empirical study | Q52938193 | ||
Medical journals: evidence of bias against the diseases of poverty | Q52949138 | ||
Impugning the integrity of medical science: the adverse effects of industry influence | Q53150497 | ||
How international are the editorial boards of leading psychiatry journals? | Q53302734 | ||
Language bias in randomised controlled trials published in English and German | Q53358085 | ||
Journals: redundant publications are bad news | Q53400252 | ||
Judging the judges: the role of journal editors | Q53406428 | ||
Multiple publication of reports of drug trials | Q53412051 | ||
Redundancy, disaggregation, and the integrity of medical research | Q56880343 | ||
Publication bias is a scientific problem with adverse ethical outcomes: the case for a section for null results | Q58671016 | ||
How international are the editorial boards of leading psychiatry journals? | Q59413285 | ||
Editorial independence and scientific publications | Q64999533 | ||
Meta-analysis and multiple publication of clinical trial reports | Q67522182 | ||
Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? | Q72537935 | ||
Increasing the trust in scientific authorship | Q73594093 | ||
Research gap in cardiovascular disease in developing countries | Q73615202 | ||
Association between time interval to publication and statistical significance | Q74208400 | ||
The uncertainty principle and industry-sponsored research | Q74252409 | ||
[Citation rates of medical German-language journals in English-language papers--do they correlate with the impact factor, and who cites? (reprint)] | Q77879475 | ||
Ghost marketing: pharmaceutical companies and ghostwritten journal articles | Q79679114 | ||
The association between impact factors and language of general internal medicine journals | Q79969166 | ||
[Impact factor of Latin American medical journals] | Q80442604 | ||
The profile of evaluators of a medical publication in relation to the response | Q82535663 | ||
[Fraud and misconduct in scientific publications] | Q84054800 | ||
P433 | issue | 1 | |
P407 | language of work or name | Spanish | Q1321 |
English | Q1860 | ||
P921 | main subject | bias | Q742736 |
P304 | page(s) | 1-5 | |
P577 | publication date | 2011-01-08 | |
P1433 | published in | Neurología | Q26841855 |
P1476 | title | Editorial bias in scientific publications | |
Sesgos en la edición de las publicaciones científicas | |||
P478 | volume | 26 |
Q83487608 | Ghost-authors, improvement article communication, and medical publications |
Q42136639 | Publication Bias in Neuroimaging Research: Implications for Meta-Analyses |
Q42397517 | Shadow enhancers: Frequently asked questions about distributed cis‐regulatory information and enhancer redundancy |
Q24289257 | US studies may overestimate effect sizes in softer research |
Search more.